Logotype for The Clorox Company

The Clorox Company (CLX) Q4 2025 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for The Clorox Company

Q4 2025 earnings summary

8 Jul, 2026

Executive summary

  • Fiscal year 2025 ended with strong margin and adjusted EPS growth, despite weaker than expected top-line growth and a challenging second half marked by market volatility and macroeconomic uncertainty.

  • Retailer inventory build ahead of a major ERP implementation temporarily boosted shipments and sales, creating significant timing noise between FY25 and FY26.

  • Digital transformation advanced with the completion of a major U.S. ERP implementation, expected to unlock long-term productivity and digital capabilities.

  • Execution challenges in certain segments, notably Kingsford and Cat litter, impacted share performance, though brand health and household penetration remained strong.

  • Consumer categories slowed in the back half of the year due to macroeconomic uncertainty, with sluggish consumption trends expected to persist into early FY26.

Financial highlights

  • Q4 organic sales growth was about 8%, with ERP shipments contributing 13–14 points, but underlying sales declined approximately 5% year-over-year.

  • Q4 gross margin was 46.5%, up 150 basis points due to ERP shipments; full-year gross margin rose 220 bps to 45.2%.

  • Q4 diluted EPS increased 55% to $2.68; adjusted EPS up 58% to $2.87, with ERP shipments adding $0.85–$0.95.

  • FY25 adjusted EPS up 25% to $7.72; net cash from operations was $981M, up 41% year-over-year.

  • Price/mix was negative 4% in Q4, driven by one-time trade spending adjustments and lapping prior year merchandising events.

Outlook and guidance

  • FY26 net sales expected to decline 6–10% year-over-year, with organic sales down 5–9% due to ERP shipment reversal.

  • FY26 organic sales growth guidance (excluding ERP impact) is -1% to +2%, with gross margin expected to be flat to down 100 bps and Adjusted EPS guidance of $5.95–$6.30 (down 23–18%).

  • ERP-related inventory build in FY25 will reverse in FY26, creating a 3.5–4% headwind to reported sales and impacting Q1 and Q4 most significantly.

  • Innovation pipeline and net revenue management initiatives are expected to drive sequential improvement, especially in the back half of FY26.

  • Tariff headwinds of ~$40 million are anticipated, to be offset by sourcing changes, productivity, and targeted pricing.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more